Target intelligence / Profile preview

Cellulose-binding domain of Humicola grisea cellulases (CBD)

Target
CBD
Molecular classification
Carbohydrate-binding module, Protein domain, Enzyme component
01

Overview

The cellulose-binding domain (CBD) of Humicola grisea cellulases is a specialized protein module that facilitates the attachment of cellulolytic enzymes to crystalline cellulose surfaces (Takashima et al., 1996, J. Biochem.). Humicola grisea, a thermophilic fungus, secretes these enzymes to break down plant biomass into fermentable sugars, a process vital for its survival and widely exploited in industrial biotechnology (UniProt P15828). The CBD, typically belonging to Carbohydrate-Binding Module (CBM) Family 1, functions by increasing the local concentration of the catalytic domain on the insoluble substrate, thereby enhancing the efficiency of cellulose hydrolysis (CAZy Database). These domains are characterized by a small, wedge-shaped structure with a flat surface containing conserved aromatic residues that stack against the glucose rings of the cellulose chain (Kleywegt et al., 1997, Structure). While highly significant in the fields of biofuels, textiles, and paper manufacturing, these domains do not play a role in human disease and are not targets for clinical drug development. They are often utilized in biotechnology as affinity tags for protein purification or as components of engineered enzymes for biomass conversion. The interaction between the CBD and cellulose is non-covalent and driven by hydrophobic interactions and hydrogen bonding.

Other names
Carbohydrate-binding moduleCBMCellulose-binding moduleHumicola grisea CBM family 1CBD
02

Mechanism of action

Not applicable; this is a biotechnological tool rather than a therapeutic target.

03

Biological functions

Cellulose bindingPolysaccharide degradationSubstrate recognitionEnzymatic hydrolysis of cellulose
04

Safety considerations

Potential for environmental allergenicityLack of therapeutic relevanceIndustrial exposure risks

Beyond the preview

Go deeper on Cellulose-binding domain of Humicola grisea cellulases (CBD).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Cellulose-binding domain of Humicola grisea cellulases (CBD).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call